$ cat ./records/gates-foundation-covid-19-commitment-reaches-1-75-billion-with-ad-2020.txt
Gates Foundation COVID-19 Commitment Reaches $1.75 Billion with Additional $250 Million Pledge
[RECORD.TXT] · cat --full
The Bill & Melinda Gates Foundation announced a further $250 million commitment to COVID-19 vaccine and treatment development and delivery, bringing total pandemic spending to $1.75 billion. The announcement emphasized international cooperation to ensure vaccines reached lower-income countries and called for manufacturing scale-up and regulatory harmonization. Bill Gates called the global vaccine development effort 'the most remarkable scientific achievement of my lifetime.'
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Gates Foundation Funds Research Into Tick Midgut Microbiome Manipulation to Block Pathogen Transmission
Next →
Gates Foundation Announces Additional $50 Million to COVAX and $20 Million to CEPI
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.